نتایج جستجو برای: copper radiopharmaceuticals

تعداد نتایج: 86023  

2014
Zhengxin Cai Qin Ouyang Dexing Zeng Kim N. Nguyen Jalpa Modi Lirong Wang Alexander G. White Buck E. Rogers Xiang-Qun Xie Carolyn J. Anderson

Somatostatin receptor subtype 2 (sstr2) is a G-protein-coupled receptor (GPCR) that is overexpressed in neuroendocrine tumors. The homology model of sstr2 was built and was used to aid the design of new somatostatin analogues modified with phosphonate-containing cross-bridged chelators for evaluation of using them as PET imaging radiopharmaceuticals. The new generation chelators were conjugated...

2011
Antoinette Y. Odendaal Ashley L. Fiamengo Riccardo Ferdani Thaddeus J. Wadas Daniel C. Hill Yijie Peng Katie J. Heroux James A. Golen Arnold L. Rheingold Carolyn J. Anderson Gary R. Weisman Edward H. Wong

Ethylene cross-bridged tetraamine macrocycles are useful chelators in coordination, catalytic, medicinal, and radiopharmaceutical chemistry. Springborg and co-workers developed trimethylene cross-bridged analogues, although their pendant-armed derivatives received little attention. We report here the synthesis of a bis-carboxymethyl pendant-armed cyclen with a trimethylene cross-bridge (C3B-DO2...

Journal: :international journal of endocrinology and metabolism 0
evangelia skoura nuclear medicine department, evangelismos hospital, athens, greece; nuclear medicine department, evangelismos hospital, ipsilandou street, athens 10676, greece. tel: +30-6946143924, fax: +30-2107259305, e-mail: [email protected]

context inherited and sporadic medullary thyroid cancer (mtc) is an uncommon and medically challenging malignancy. even if the extent of initial surgery is deemed adequate, the recurrence rate remains high, up to 50% in most series. measurement of serum calcitonin is important in the follow-up of patients with mtc, and reliably reflects the existence of the disease. evidence acquisition there i...

Journal: :Journal of nuclear medicine technology 2008
Ahmad Mushtaq Taj Ur Rehman Muhammad Safdar Mansur Mustanser Jehangir

UNLABELLED Many groups have reported the adsorption or retention of (99m)Tc-radiopharmaceuticals on injection vials and disposable plastic syringes. Such an enormously high loss of radioactivity would result in poor images, radiation exposure, waste, and economic burdens. We therefore decided to investigate the extent of adsorption or retention of several (99m)Tc-radiopharmaceuticals on injecti...

2017
Michele Iori Pier C Capponi Sara Rubagotti Luca Rosario Esposizione Johanna Seemann Riccardo Pitzschler Thorsten Dreger Debora Formisano Elisa Grassi Federica Fioroni Annibale Versari Mattia Asti

In spite of the hazard due to the radiation exposure, preparation of 90Y- and 177Lu-labelled radiopharmaceuticals is still mainly performed using manual procedures. In the present study the performance of a commercial automatic synthesizer based on disposable cassettes for the labelling of 177Lu- and 90Y-DOTA-conjugated biomolecules (namely, DOTATOC and PSMA-617) was evaluated and compared to a...

2015
Emma Aneheim Per Albertsson Tom Bäck Holger Jensen Stig Palm Sture Lindegren

To facilitate multicentre clinical studies on targeted alpha therapy, it is necessary to develop an automated, on-site procedure for conjugating rare, short-lived, alpha-emitting radionuclides to biomolecules. Astatine-211 is one of the few alpha-emitting nuclides with appropriate chemical and physical properties for use in targeted therapies for cancer. Due to the very short range of the emitt...

Journal: :journal of biomedical physics and engineering 0
a. r. shirazi department of medical physics and biomedical engineering, faculty of medicine, tehran university of medical sciences, tehran, iran z. mehdipour department of medical radiation engineering, science and research branch, islamic azad university, tehran, iran a. r. jalilian radiopharmaceutical research and development lab, nuclear science and technology research institute (nstri), tehran, iran e. mihandoost department of medical radiation engineering, science and research branch, islamic azad university, tehran, iran

background: gts, ptsm and atsm are bis-thiosemicarbazone ligands used in the preparation of copper radiopharmaceuticals. chemical structure of these materials indicates that they should have radio-protective effects. objective: to study the radio-protective effects of gts, ptsm and atsm. methods: this study has focused on radio-protective effects of these compounds at different doses (20, 40 an...

Journal: :asia oceania journal of nuclear medicine and biology 0
alireza aslani department of nuclear medicine, royal north shore hospital, sydney, australia graeme m snowdon department of nuclear medicine, royal north shore hospital, sydney, australia dale l bailey faculty of health sciences, university of sydney, sydney, australia geoffrey p schembri department of nuclear medicine, royal north shore hospital, sydney, australia elizabeth a bailey department of nuclear medicine, royal north shore hospital, sydney, australia paul j roach sydney medical school, university of sydney, sydney, australia

objective(s): gallium‐68 (ga‐68) is an ideal research and hospital‐based pet radioisotope. currently, the main form of ga‐68 radiopharmaceutical that is being synthesised in‐house is ga‐68 conjugated with dota based derivatives. the development of automated synthesis systems has increased the reliability, reproducibility and safety of radiopharmaceutical productions. here we report on our three...

Journal: :Biomedical Journal of Scientific and Technical Research 2023

Molecular imaging is commonly used to improve the diagnosis and treatment of cancer. Nuclear medicine offers cutting-edge procedures instruments, computers radiopharmaceuticals for various diseases, including oncology indications. The detailed images provided by positron emission tomography (PET) can accurately image biochemical or physiologic/pathologic phenomena.

Journal: :BoneKEy reports 2015
Tilman D Rachner Franz Jakob Lorenz C Hofbauer

The treatment of bone metastases remains a clinical challenge. Although a number of well-established agents, namely bisphosphonates and denosumab, are available to reduce the occurrence of skeletal-related events, additional cancer-targeted therapies are required to improve patients' prognosis and quality of life. This review focuses on novel targets and agents that are under clinical evaluatio...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید